F98 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - CytoMed Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.75 EUR 2.74%

Market Cap: €8.8m

	CytoMed Therapeutics Ltd F:F98	SG
B	Bank Pan Indonesia Tbk PT XMUN:PTQ	ID
F	Food and Drinks PCL SET:F&D	TH
B	BGT Corporation PCL SET:BGT	TH
	Interpump Group SpA OTC:IPGLF	IT
P	PRTR Group PCL SET:PRTR	TH
O	Optimind Pharma Corp CNSX:OMND	CA
S	Simat Technologies PCL SET:SIMAT	TH
B	BCPG PCL SET:BCPG	TH
S	SAPPE PCL SET:SAPPE	TH

Profitability Summary

CytoMed Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Strong 3Y Average Gross Margin

64%

Negative Operating Margin

-1,228%

Negative 3Y Average Operating Margin

-1,870%

Negative Net Margin

-1,076%

Negative 3Y Average Net Margin

-1,888%

Negative Free Cash Flow Margin

-1,315%

Negative 3Y Average Free Cash Flow Margin

-2,633%

Negative ROE

-58%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-79%

ROIC is Increasing

-121% > -73%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.